{"id":97343,"date":"2026-05-27T11:38:30","date_gmt":"2026-05-27T06:08:30","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=97343"},"modified":"2026-05-27T11:38:31","modified_gmt":"2026-05-27T06:08:31","slug":"sudeep-pharma-analyst-review-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/sudeep-pharma-analyst-review-2026\/","title":{"rendered":"Sudeep Pharma Analyst Review May 2026"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p>This <strong><a href=\"https:\/\/univest.in\/user\/stocks\/sudeepphrm\/sudeep-pharma-ltd-share-price-today\">Sudeep Pharma<\/a> analyst review<\/strong> for May 2026 covers all critical data investors need for SUDEEPPHRM at Rs 696.80. Sudeep Pharma is a pharmaceutical API manufacturer. This <strong>Sudeep Pharma analyst review<\/strong> analyses technical levels, business fundamentals, valuation, and key risks for SUDEEPPHRM through FY27.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-analyst-review-2026\/#Sudeep_Pharma_Analyst_Review_Company_Snapshot_May_2026\" title=\"Sudeep Pharma Analyst Review: Company Snapshot May 2026\">Sudeep Pharma Analyst Review: Company Snapshot May 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-analyst-review-2026\/#Analyst_Insight_Sudeep_Pharma_Analyst_Review_for_FY27\" title=\"Analyst Insight: Sudeep Pharma Analyst Review for FY27\">Analyst Insight: Sudeep Pharma Analyst Review for FY27<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-analyst-review-2026\/#Technical_Analysis_in_This_Sudeep_Pharma_Analyst_Review\" title=\"Technical Analysis in This Sudeep Pharma Analyst Review\">Technical Analysis in This Sudeep Pharma Analyst Review<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-analyst-review-2026\/#Support_and_Resistance_in_This_Sudeep_Pharma_Analyst_Review\" title=\"Support and Resistance in This Sudeep Pharma Analyst Review\">Support and Resistance in This Sudeep Pharma Analyst Review<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-analyst-review-2026\/#Business_Segments_in_This_Sudeep_Pharma_Analyst_Review\" title=\"Business Segments in This Sudeep Pharma Analyst Review\">Business Segments in This Sudeep Pharma Analyst Review<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-analyst-review-2026\/#API_Manufacturing_for_Regulated_Markets\" title=\"API Manufacturing for Regulated Markets\">API Manufacturing for Regulated Markets<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-analyst-review-2026\/#Specialty_Pharma_Ingredients\" title=\"Specialty Pharma Ingredients\">Specialty Pharma Ingredients<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-analyst-review-2026\/#Export_to_Global_Pharma_Companies\" title=\"Export to Global Pharma Companies\">Export to Global Pharma Companies<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-analyst-review-2026\/#Valuation_Sudeep_Pharma_Analyst_Review_Bull_Bear_Base_Case\" title=\"Valuation: Sudeep Pharma Analyst Review Bull Bear Base Case\">Valuation: Sudeep Pharma Analyst Review Bull Bear Base Case<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-analyst-review-2026\/#FY27_Outlook_in_This_Sudeep_Pharma_Analyst_Review\" title=\"FY27 Outlook in This Sudeep Pharma Analyst Review\">FY27 Outlook in This Sudeep Pharma Analyst Review<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-analyst-review-2026\/#Key_Risks_in_This_Sudeep_Pharma_Analyst_Review\" title=\"Key Risks in This Sudeep Pharma Analyst Review\">Key Risks in This Sudeep Pharma Analyst Review<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-analyst-review-2026\/#Conclusion_Sudeep_Pharma_Analyst_Review_Verdict_May_2026\" title=\"Conclusion: Sudeep Pharma Analyst Review Verdict May 2026\">Conclusion: Sudeep Pharma Analyst Review Verdict May 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-analyst-review-2026\/#FAQs_Sudeep_Pharma_Analyst_Review_2026\" title=\"FAQs: Sudeep Pharma Analyst Review 2026\">FAQs: Sudeep Pharma Analyst Review 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-analyst-review-2026\/#What_is_the_analyst_target_for_Sudeep_Pharma_in_2026\" title=\"What is the analyst target for Sudeep Pharma in 2026?\">What is the analyst target for Sudeep Pharma in 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-analyst-review-2026\/#Is_Sudeep_Pharma_a_good_buy_at_Rs_69680\" title=\"Is Sudeep Pharma a good buy at Rs 696.80?\">Is Sudeep Pharma a good buy at Rs 696.80?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-analyst-review-2026\/#What_is_the_52-week_high_and_low_of_Sudeep_Pharma\" title=\"What is the 52-week high and low of Sudeep Pharma?\">What is the 52-week high and low of Sudeep Pharma?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-analyst-review-2026\/#What_are_the_key_risks_for_Sudeep_Pharma\" title=\"What are the key risks for Sudeep Pharma?\">What are the key risks for Sudeep Pharma?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-analyst-review-2026\/#Where_can_I_track_live_data_for_Sudeep_Pharma\" title=\"Where can I track live data for Sudeep Pharma?\">Where can I track live data for Sudeep Pharma?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Sudeep_Pharma_Analyst_Review_Company_Snapshot_May_2026\"><\/span><strong>Sudeep Pharma Analyst Review: Company Snapshot May 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Sudeep Pharma produces active pharmaceutical ingredients for regulated and semi-regulated markets. The table below summarises key metrics for this <strong>Sudeep Pharma analyst review<\/strong>.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Parameter<\/th>\n<th>Value<\/th>\n<\/tr>\n<tr>\n<td>NSE Ticker<\/td>\n<td>SUDEEPPHRM<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Pharmaceuticals &#8211; APIs<\/td>\n<\/tr>\n<tr>\n<td>CMP (May 2026)<\/td>\n<td>Rs 696.80<\/td>\n<\/tr>\n<tr>\n<td>52 Week High<\/td>\n<td>Rs 766.45<\/td>\n<\/tr>\n<tr>\n<td>52 Week Low<\/td>\n<td>Rs 627.15<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 3500 Crore<\/td>\n<\/tr>\n<tr>\n<td>Trailing P\/E<\/td>\n<td>35x<\/td>\n<\/tr>\n<tr>\n<td>Analyst Consensus Target<\/td>\n<td>Rs 871.00<\/td>\n<\/tr>\n<tr>\n<td>Bull Case Target<\/td>\n<td>Rs 1080.04<\/td>\n<\/tr>\n<tr>\n<td>Bear Case Target<\/td>\n<td>Rs 592.28<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Analyst_Insight_Sudeep_Pharma_Analyst_Review_for_FY27\"><\/span><strong>Analyst Insight: Sudeep Pharma Analyst Review for FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Senior Research Analyst <strong>Ankit Jaiswal<\/strong> flags Sudeep Pharma as a stock to watch in May 2026. At Rs 696.80, Ankit Jaiswal identifies key support in the Rs 639.69 to Rs 661.96 band and resistance near Rs 738.61. He suggests watching Sudeep Pharma for a potential move toward Rs 871.00. Ankit Jaiswal&#8217;s view in this <strong>Sudeep Pharma analyst review<\/strong> does not constitute a trade recommendation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Technical_Analysis_in_This_Sudeep_Pharma_Analyst_Review\"><\/span><strong>Technical Analysis in This Sudeep Pharma Analyst Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This <strong>Sudeep Pharma analyst review<\/strong> places SUDEEPPHRM at Rs 696.80 within its 52-week band of Rs 627.15 to Rs 766.45. The 14-day RSI, MACD signal, and volume profile are key technical inputs when evaluating SUDEEPPHRM.<\/p>\n<p>The <strong>Sudeep Pharma analyst review<\/strong> identifies support in the Rs 639.69 to Rs 661.96 range and resistance in the Rs 738.61 to Rs 783.90 zone. A sustained close above Rs 738.61 could signal momentum toward the analyst consensus target of Rs 871.00.<\/p>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Screen the best stocks on the Univest Screener.<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Support_and_Resistance_in_This_Sudeep_Pharma_Analyst_Review\"><\/span><strong>Support and Resistance in This Sudeep Pharma Analyst Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Support Zone:<\/strong> Rs 639.69 to Rs 661.96 &#8211; this <strong>Sudeep Pharma analyst review<\/strong> identifies this as a potential accumulation signal for SUDEEPPHRM.<\/li>\n<li><strong>Resistance Zone:<\/strong> Rs 738.61 to Rs 783.90 &#8211; the <strong>Sudeep Pharma analyst review<\/strong> flags a close above Rs 738.61 as a positive signal for SUDEEPPHRM.<\/li>\n<li><strong>Consensus Target:<\/strong> Rs 871.00 is the base-case target in this <strong>Sudeep Pharma analyst review<\/strong>.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Business_Segments_in_This_Sudeep_Pharma_Analyst_Review\"><\/span><strong>Business Segments in This Sudeep Pharma Analyst Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"API_Manufacturing_for_Regulated_Markets\"><\/span><strong>API Manufacturing for Regulated Markets<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>This primary segment drives revenue and margin for Sudeep Pharma, supporting the earnings trajectory toward Rs 871.00 in this <strong>Sudeep Pharma analyst review<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Specialty_Pharma_Ingredients\"><\/span><strong>Specialty Pharma Ingredients<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>This segment adds meaningful scale to Sudeep Pharma&#8217;s model and is a key EPS contributor through FY27 as identified in this <strong>Sudeep Pharma analyst review<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Export_to_Global_Pharma_Companies\"><\/span><strong>Export to Global Pharma Companies<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>This growth frontier is a potential re-rating catalyst for SUDEEPPHRM and a key element of this <strong>Sudeep Pharma analyst review<\/strong>.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Valuation_Sudeep_Pharma_Analyst_Review_Bull_Bear_Base_Case\"><\/span><strong>Valuation: Sudeep Pharma Analyst Review Bull Bear Base Case<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>At Rs 696.80 and P\/E of 35x, this <strong>Sudeep Pharma analyst review<\/strong> sets three scenarios: bull case Rs 1080.04, base case Rs 871.00, and bear case Rs 592.28.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Scenario<\/th>\n<th>Target Price<\/th>\n<th>Key Condition<\/th>\n<\/tr>\n<tr>\n<td>Bull Case<\/td>\n<td>Rs 1080.04<\/td>\n<td>Strong FY27 delivery and Pharmaceuticals &#8211; APIs re-rating<\/td>\n<\/tr>\n<tr>\n<td>Base Case<\/td>\n<td>Rs 871.00<\/td>\n<td>Moderate growth per analyst consensus in this Sudeep Pharma analyst review<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>Rs 592.28<\/td>\n<td>Earnings miss or macro headwinds for SUDEEPPHRM<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"FY27_Outlook_in_This_Sudeep_Pharma_Analyst_Review\"><\/span><strong>FY27 Outlook in This Sudeep Pharma Analyst Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This <strong>Sudeep Pharma analyst review<\/strong> for FY27 is constructive provided SUDEEPPHRM delivers on earnings expectations. Q1 FY27 results will be the first checkpoint. Investors should monitor Pharmaceuticals &#8211; APIs indicators, RBI policy, and FII flow trends.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_in_This_Sudeep_Pharma_Analyst_Review\"><\/span><strong>Key Risks in This Sudeep Pharma Analyst Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This <strong>Sudeep Pharma analyst review<\/strong> identifies four key risks for SUDEEPPHRM: macro slowdown, input cost pressure, FII selling, and Q1 FY27 earnings disappointment.<\/p>\n<p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or the <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to get daily stock recommendations and expert research.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion_Sudeep_Pharma_Analyst_Review_Verdict_May_2026\"><\/span><strong>Conclusion: Sudeep Pharma Analyst Review Verdict May 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This <strong>Sudeep Pharma analyst review<\/strong> concludes that SUDEEPPHRM at Rs 696.80 presents a defined risk-reward with consensus target Rs 871.00. The 52-week range of Rs 627.15 to Rs 766.45 provides further context. Use this <strong>Sudeep Pharma analyst review<\/strong> as a research reference and consult a SEBI-registered advisor before investing in SUDEEPPHRM.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_Sudeep_Pharma_Analyst_Review_2026\"><\/span><strong>FAQs: Sudeep Pharma Analyst Review 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_analyst_target_for_Sudeep_Pharma_in_2026\"><\/span><strong>What is the analyst target for Sudeep Pharma in 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>Sudeep Pharma analyst review<\/strong> consensus target is Rs 871.00, bull case Rs 1080.04, bear case Rs 592.28.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Sudeep_Pharma_a_good_buy_at_Rs_69680\"><\/span><strong>Is Sudeep Pharma a good buy at Rs 696.80?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>At Rs 696.80 with PE 35x and target Rs 871.00, this <strong>Sudeep Pharma analyst review<\/strong> is constructive for 12-month investors. Consult a SEBI-registered advisor before acting on this <strong>Sudeep Pharma analyst review<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_52-week_high_and_low_of_Sudeep_Pharma\"><\/span><strong>What is the 52-week high and low of Sudeep Pharma?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>52-week high is Rs 766.45 and 52-week low is Rs 627.15. This <strong>Sudeep Pharma analyst review<\/strong> contextualises SUDEEPPHRM at Rs 696.80 within this range.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_for_Sudeep_Pharma\"><\/span><strong>What are the key risks for Sudeep Pharma?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Key risks in this <strong>Sudeep Pharma analyst review<\/strong>: macro slowdown, input cost pressure, FII selling, and competitive pressure in the Pharmaceuticals &#8211; APIs sector.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_track_live_data_for_Sudeep_Pharma\"><\/span><strong>Where can I track live data for Sudeep Pharma?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Track Sudeep Pharma&#8217;s live price on the Univest Screener to complement this <strong>Sudeep Pharma analyst review<\/strong> with real-time data.<\/p>\n<p><em>Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered financial advisor before making any investment decisions.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sudeep Pharma analyst review 2026: CMP Rs 696.80, MCap Rs 3500 Cr, PE 35x. Pharmaceuticals &#8211; APIs outlook. May 2026.<\/p>\n","protected":false},"author":26,"featured_media":98515,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-97343","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1779862129:26"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["75"],"rank_math_focus_keyword":["Sudeep Pharma Analyst Review"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_title":["Sudeep Pharma Analyst Review 2026: Key Levels and Outlook"],"rank_math_description":["Sudeep Pharma analyst review 2026: CMP Rs 696.80, MCap Rs 3500 Cr, PE 35x. Pharmaceuticals - APIs outlook. May 2026."],"_wp_old_date":["2026-05-25"],"_thumbnail_id":["98515"],"_edit_last":["26"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["13686"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/05\/Sudeep-Pharma-Analyst-Review.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/97343","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=97343"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/97343\/revisions"}],"predecessor-version":[{"id":98519,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/97343\/revisions\/98519"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/98515"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=97343"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=97343"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=97343"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}